04:31 PM EDT, 06/02/2025 (MT Newswires) -- Trevi Therapeutics ( TRVI ) disclosed on Monday that it has commenced a public offering of its common stock to raise $100 million for the biopharmaceutical company.

Trevi also expects to provide underwriters with a 30-day option to buy up to $15 million of its shares in addition to any stock sold through the upcoming deal to cover potential overallotments, it said.

Any offering would be subject to market and other conditions, the company said.

Trevi shares were recently sinking more than 3% during Monday's after-hours session.